VTRS FY 2022 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$17B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16.3B-9.1% YoY

Gross Profit

$6.5B40.0% margin

Operating Income

$1.6B9.9% margin

Net Income

$2.1B12.8% margin

EPS (Diluted)

$1.71

Cash Flow

Operating Cash Flow

$3.0B

Free Cash Flow

$2.5B

Stock-Based Comp.

$116M

Balance Sheet

Total Assets

$50.0B

Total Liabilities

$28.9B

Stockholders' Equity

$21.1B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.3B	$17.9B	-9.1%
Gross Profit	$6.5B	$5.6B	+16.5%
Operating Income	$1.6B	-$34M	+4849.7%
Net Income	$2.1B	-$1.3B	+263.8%